Please wait a minute...
Frontiers of Medicine

ISSN 2095-0217

ISSN 2095-0225(Online)

CN 11-5983/R

Postal Subscription Code 80-967

2018 Impact Factor: 1.847

Front Med Chin    2010, Vol. 4 Issue (3) : 275-279    https://doi.org/10.1007/s11684-010-0101-y
REVIEW
Pathogenesis, diagnosis, and treatment of recurrent spontaneous abortion with immune type
Qi-De LIN(), Li-Hua QIU
Department of Obstetrics and Gynecology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China
 Download: PDF(87 KB)   HTML
 Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks
Abstract

Recurrent spontaneous abortion (RSA), defined as three or more consecutive pregnancy losses before 20 weeks of gestation, is difficult to treat in the clinical setting. It affects 1%–5% of women of reproductive age. In the investigations of immunopathogenesis, diagnosis, and treatment of RSA since the late 1980s, it was found that RSA was associated with abnormal maternal local or systemic immune response. The pathogenesis of autoimmune RSA was mainly associated with antiphospholipid antibody (APA), while that of alloimmune RSA was due to the disturbance of maternofetal immunological tolerance. Systemic etiological screening process and diagnosis systems of RSA with immune type were developed, and anticardiolipin (ACL or ACA) + anti-β2-GP1 antibody combining multiple assays for effective diagnosis of RSA with autoimmune type was first established. According to the dynamic monitoring of clinical parameters before and during gestation, low-dose, short-course, and individual immunosuppressive therapy and lymphocyte immunotherapy for RSA with immune type were carried out. The outcomes of the offsprings of patients with RSA were followed up, and the safety and validity of the therapies were confirmed. The research achievement leads to great progress in the diagnosis and treatment of RSA in China.

Keywords spontaneous abortion, recurrent      autoimmune      alloimmune      pathogenesis      diagnosis      immunotherapy     
Corresponding Author(s): LIN Qi-De,Email:shlinqide@hotmail.com   
Issue Date: 05 September 2010
 Cite this article:   
Qi-De LIN,Li-Hua QIU. Pathogenesis, diagnosis, and treatment of recurrent spontaneous abortion with immune type[J]. Front Med Chin, 2010, 4(3): 275-279.
 URL:  
https://academic.hep.com.cn/fmd/EN/10.1007/s11684-010-0101-y
https://academic.hep.com.cn/fmd/EN/Y2010/V4/I3/275
1 Lin Q D, Zhou H C, Zhao A M, Yan J H, Wu Y F, Tang X W, Zhu L H, Di W, Kang J F, Wang Y, Chen S L, Jiang B Z, Chen M S. The relationship between recurrent spontaneous abortion and autoantibodies. Zhonghua Fu Chan Ke Za Zhi , 1993, 28(11): 674-677 (in Chinese)
2 Zhao A M, Lin Q D, Zhou H C, Jiang L L, Yan J H, Wu Y F. Immunohistochemical study on the decidua vessels in recurrent spontaneous abortion. Zhonghua Fu Chan Ke Za Zhi , 1997, 32(11): 674-677 (in Chinese)
3 Tan Y Y, Lin Q D, Zhao A M. The relationship between recurrent spontaneous abortion and anticardiolipin antibody. Zhongguo Mian Yi Xue Za Zhi , 1999, 15(12): 545-546
4 Wang X P, Ma Z H, Lin Q D. Inherited thrombophilia in recurrent spontaneous abortion among Chinese women. Int J Gynaecol Obstet , 2006, 92(3): 264-265
doi: 10.1016/j.ijgo.2005.12.008
5 Wang X P, Lin Q D, Ma Z W, Zhao A M. C677T and A1298C mutation of the methylenetetrahydrofolate reductase gene in unexplained recurrent spontaneous abortion. Zhonghua Fu Chan Ke Za Zhi , 2004, 39(4): 238-241 (in Chinese)
6 Wang X P, Ma Z H, Hong Y, Zhao A M, Qiu L H, Lu P H, Lin Q D. The skewed TCR-BV repertoire displayed at the maternal-fetal interface of women with unexplained pregnancy loss. Am J Reprod Immunol , 2005, 54(2): 84-95
doi: 10.1111/j.1600-0897.2005.00291.x
7 Wang X P, Lin Q D, Ma Z W, Hong Y, Zhao A M, Di W, Lu P H. Association of the A/G polymorphism at position 49 in exon 1 of CTLA-4 with the susceptibility to unexplained recurrent spontaneous abortion in the Chinese population. Am J Reprod Immunol , 2005, 53(2): 100-105
doi: 10.1111/j.1600-0897.2004.00251.x
8 Wang X P, Lin Q D, Ma Z W, Hong Y, Zhao A M, Di W, Lu P H. A/G polymorphism at position 49 in exon 1 of CTLA-4 gene in Chinese women with unexplained recurrent spontaneous abortion. Zhonghua Fu Chan Ke Za Zhi , 2006, 41(3): 155-158 (in Chinese)
9 Qiu L H, Lin Q D. Study on the relationship between regulatory T cells and unexplained recurrent spontaneous abortion. Zhonghua Fu Chan Ke Za Zhi , 2004, 39(12): 816-818 (in Chinese)
10 Yang H, Qiu L H, Chen G J, Ye Z, Lü C J, Lin Q D. Proportional change of CD4+CD25+ regulatory T cells in unexplained recurrent spontaneous abortion patients. Fertil Steril , 2008, 89(3): 656-661
doi: 10.1016/j.fertnstert.2007.03.037
11 Yang H, Qiu L, Di W, Zhao A, Chen G, Hu K, Lin Q. Proportional change of CD4+CD25+ regulatory T cells after lymphocyte therapy in unexplained recurrent spontaneous abortion patients. Fertil Steril , 2009, 92(1): 301-305
doi: 10.1016/j.fertnstert.2008.04.068
12 Qiu L H, Lin Q D, Shen Z Y, Lu P H, Li D Z, Hong Y. The influence of active immunotherapy on serum T helper cell type 1 and 2 cytokines balance in unexplained habitual abortion patients. Zhonghua Fu Chan Ke Za Zhi , 2002, 37(6): 368-369 (in Chinese)
13 Qiu L H, Lin Q D, Hong Y, Li D Z, Ding C W. Study on changes of serum T helper cell type 1 and 2 cytokines after active immunotherapy in women with unexplained habitual abortion. Zhonghua Fu Chan Ke Za Zhi , 2001, 36(7): 408-410 (in Chinese)
14 Wang W J, Hao C F, Yi-Lin, Yin G J, Bao S H, Qiu L H, Lin Q D. Increased prevalence of T helper 17 (Th17) cells in peripheral blood and decidua in unexplained recurrent spontaneous abortion patients. J Reprod Immunol , 2010, 84(2): 164-170
doi: 10.1016/j.jri.2009.12.003
15 Hong Y, LinQD, Wang XP. The relationship between the expression of KIR’ repertoire in decidua and unexplained spontaneous abortion. Xiandai Fuchanke Jinzhan , 2005, 14(3): 214-217 (in Chinese)
16 Lin Y, Chen Y, Zeng Y, Wang T, Zeng S. Lymphocyte phenotyping and NK cell activity analysis in pregnant NOD/SCID mice. J Reprod Immunol , 2005, 68(1-2): 39-51
doi: 10.1016/j.jri.2005.05.002
17 Lin Y, Liang Z H, Chen Y J, Zeng Y Y. TLR3-involved modulation of pregnancy tolerance in double-stranded RNA-stimulated NOD/SCID mice. J Immunol , 2006, 176(7): 4147-4154
18 Jin Y, Lin Q D, Wang X P, Xiao Y S, Lü C J, Ding C W. Expression of TSP1, CD36, CD47 and cytokine secretion on macrophage of women with unexplained recurrent spontaneous abortion. Xiandai Fu Chan Ke Jin Zhan , 2006, 15(12): 926-929 (in Chinese)
19 Wang X P, Lin Q D, Lu P H, Ma Z W, Zhao A M. Association of HLA-DQB1 coding region with unexplained recurrent spontaneous abortion. Chin Med J (Engl) , 2004, 117(4): 492-497
20 Lin Q D. Recurrent spontaneous abortion and habitual abortion caused by immune factors. Zhonghua Fu Chan Ke Za Zhi , 2000, 35(12): 760 (in Chinese)
21 Lin Q D, Jin Y. How to standardize the etiology screening and theatment of recurrent spontaneous abortion? Shiyong Fu Chan Ke Za Zhi , 2005, 21(2): 66-68 (in Chinese)
22 Lin Q D, Zhou H C, Zhao A M, Yan J H, Wu Y F, Tang X W, Zhu L H, Di W, Kang J F, Wang Y, Chen S L, Jiang B Z, Chen M S. Immunological diagnosis and treatment of unexplained recurrent spontaneous abortion. Zhonghua Fu Chan Ke Za Zhi , 1993, 28(3): 143 (in Chinese)
23 Bao S H, Wang X P, Lin Q D, Di W, Xu L, Ding C W. The investigation on the value of repeat and combination test of ACA and anti-β2-GPI antibody in women with recurrent spontaneous abortion. Am J Reprod Immunol , 2008, 60(4): 372-378
doi: 10.1111/j.1600-0897.2008.00638.x
24 Xu L, Lin Q D, Wang X P, Zhao A M. The application of individualized immune-s uppression and anticoagulant in therapy of RSA with ACA. Zhongguo Shi Yong Fu Ke Yu Chan Ke Za Zhi , 2006, 22(9): 666-668 (in Chinese)
25 Chen Q H, Lin Q D, Zhao A M, Zhou Y, Tang X W, Yan J H. Following up the offspring of the unexplained recurrent spontaneous abortion women receiving active immunotherapy. Zhonghua Fu Chan Ke Za Zhi , 1997, 32(1): 44-45 (in Chinese)
26 Zheng X G, Huang L P, Lin Q D, Wang X P, Lin J H, Di W, Kong X M. Following up the offspring of the recurrent spontaneous abortion women with anticardiolipin antibody receiving the individual therapy with immune-suppression and anticoagulant therapy. Zhongguo Shi Yong Fu Ke Yu Chan Ke Za Zhi , 2008, 24(3): 192-194 (in Chinese)
[1] Yong Fan, Yan Geng, Lin Shen, Zhuoli Zhang. Advances on immune-related adverse events associated with immune checkpoint inhibitors[J]. Front. Med., 2021, 15(1): 33-42.
[2] Hongnan Mo, Binghe Xu. Progress in systemic therapy for triple-negative breast cancer[J]. Front. Med., 2021, 15(1): 1-10.
[3] Ching-Hon Pui. Precision medicine in acute lymphoblastic leukemia[J]. Front. Med., 2020, 14(6): 689-700.
[4] Dongping Ning, Zhan Zhang, Kun Qiu, Lin Lu, Qin Zhang, Yan Zhu, Renzhi Wang. Efficacy of intelligent diagnosis with a dynamic uncertain causality graph model for rare disorders of sex development[J]. Front. Med., 2020, 14(4): 498-505.
[5] Yang Jiao, Zhan Zhang, Ting Zhang, Wen Shi, Yan Zhu, Jie Hu, Qin Zhang. Development of an artificial intelligence diagnostic model based on dynamic uncertain causality graph for the differential diagnosis of dyspnea[J]. Front. Med., 2020, 14(4): 488-497.
[6] Guangbiao Zhou, Saijuan Chen, Zhu Chen. Advances in COVID-19: the virus, the pathogenesis, and evidence-based control and therapeutic strategies[J]. Front. Med., 2020, 14(2): 117-125.
[7] Qiaoshuai Lan, Shuai Xia, Qian Wang, Wei Xu, Haiyan Huang, Shibo Jiang, Lu Lu. Development of oncolytic virotherapy: from genetic modification to combination therapy[J]. Front. Med., 2020, 14(2): 160-184.
[8] Hanyu Zhu, Bo Fu, Yong Wang, Jing Gao, Qiuxia Han, Wenjia Geng, Xiaoli Yang, Guangyan Cai, Xiangmei Chen, Dong Zhang. Comparative analysis of membranous and other nephropathy subtypes and establishment of a diagnostic model[J]. Front. Med., 2019, 13(5): 618-625.
[9] Xiaolin Fan, Yanzhen Xiong, Yuan Wang. A reignited debate over the cell(s) of origin for glioblastoma and its clinical implications[J]. Front. Med., 2019, 13(5): 531-539.
[10] Yumeng Wang, Guiling Li. PD-1/PD-L1 blockade in cervical cancer: current studies and perspectives[J]. Front. Med., 2019, 13(4): 438-450.
[11] Synat Kang, Yanyan Li, Yifeng Bao, Yi Li. High-affinity T cell receptors redirect cytokine-activated T cells (CAT) to kill cancer cells[J]. Front. Med., 2019, 13(1): 69-82.
[12] Zhao Zhang, Jun Jiang, Xiaodong Wu, Mengyao Zhang, Dan Luo, Renyu Zhang, Shiyou Li, Youwen He, Huijie Bian, Zhinan Chen. Chimeric antigen receptor T cell targeting EGFRvIII for metastatic lung cancer therapy[J]. Front. Med., 2019, 13(1): 57-68.
[13] Min Zhang, Jingwen Yang, Wenjing Hua, Zhong Li, Zenghui Xu, Qijun Qian. Monitoring checkpoint inhibitors: predictive biomarkers in immunotherapy[J]. Front. Med., 2019, 13(1): 32-44.
[14] Renyu Zhang, Zhao Zhang, Zekun Liu, Ding Wei, Xiaodong Wu, Huijie Bian, Zhinan Chen. Adoptive cell transfer therapy for hepatocellular carcinoma[J]. Front. Med., 2019, 13(1): 3-11.
[15] Liru Qiu, Fengjie Yang, Yonghua He, Huiqing Yuan, Jianhua Zhou. Clinical characterization and diagnosis of cystic fibrosis through exome sequencing in Chinese infants with Bartter-syndrome-like hypokalemia alkalosis[J]. Front. Med., 2018, 12(5): 550-558.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed